Strides Shasun Gets US Drug Regulator's Approval For Parkinsons Drug

New Delhi: Strides Shasun today said it has received approval from the US health regulator for Amantadine Hydrochloride, used for the treatment of Parkinsons disease and select viral infections, in the American market. "The product has received approval in 15 months under the USFDA's new product clearance regime of GDUFA. The product will be launched immediately," Strides Shasun said in a BSE filing. Amantadine Hydrochloride is use...